Classification of human liposarcoma and lipoma using ex vivo proton NMR spectroscopy
Kevin K. Millis(Harvard University), Samuel Singer(Memorial Sloan Kettering Cancer Center), David G. Cory(University of Waterloo), Christopher D.�M. Fletcher(Brigham and Women's Hospital), Patrick Weybright(Harvard University), Natalee Campbell(Brigham and Women's Hospital), Jonathan A. Fletcher(Harvard University)
Magnetic Resonance in Medicine
February 1, 1999
Cited by 6
Related Papers
Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial
|The Lancet|2012|2.1k
Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells
|Nature Biotechnology|2000|1.7k
Identification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing
|Nature Genetics|2013|818
Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy
|Nature Genetics|2010|725
TPM3-ALK and TPM4-ALK Oncogenes in Inflammatory Myofibroblastic Tumors
|American Journal Of Pathology|2000|716